The objective of this study is to investigate an eŠect on the antimicrobial appropriate use of the antimicrobial stewardship. We investigated the consumption of injectable antimicrobials from 2001 to 2007 and the administration period of speciˆc antimicrobials (carbapenems, fourth-generation cephalosporins, anti-methicillin-resistant Staphylococcus aureus (MRSA) agents) in the individual patient. Since September 2004, the infection control team at Osaka University Hospital has been promoting appropriate use of antimicrobials through consultation, education, and weekly surveillance of speciˆc antimicrobial usage. We obtained the amount of all antimicrobial injections as titer from the medical information database of the electronic medical chart system retrospectively. Antimicrobial use densities (AUD) were evaluated by measuring the number of doses administered/1000 patient-days. Although the number of inpatient admissions and operations increased 1.53-and 1.39-fold, respectively, in the seven years from 2001 to 2007, the expenditure on speciˆc antimicrobials decreased markedly with AUD of speciˆc antimicrobials decreasing from 39.6 to 29.2. The percentage of inpatients receiving speciˆc antimicrobials decreased from 19.8％ to 9.8％, and the ratio of the number of inpatients administered a speciˆc antimicrobial within seven days to the number of inpatients administered each speciˆc antimicrobial increased to over 60％. This led to reduction in the total expenditure of antimicrobials by about \100 million annually. The incidence of hospital-associated MRSA (HA-MRSA) infection decreased from 0.93％ (2003) to 0.68％ (2007). We can reduce the expenditure of antimicrobials without increasing incidence of the HA-MRSA by antimicrobial stewardship, and we think that appropriate use of antimicrobials is achieved progressively.
INTRODUCTION
The cost of antimicrobial agents is estimated to constitute about one-third of the pharmacy budget in general hospitals. 1, 2) It is reported that 25 50％ of inpatients receive antimicrobial agents 3) and 30 50％ of all courses of antimicrobial therapy are thought to be unnecessary. 4, 5) In addition to the toxicity of the administered drug, excessive and long-term administration of antimicrobials causes signiˆcant adverse effects, such as emergence of resistant microorganisms, increase in morbidity, and associated infections. 6, 7) It also results in an increase in healthcare costs. 8 10) In particular, the emergence of multidrug-resistant organisms (MDROs) such as methicillin-resistant Staphylococcus aureus (MRSA) and multidrugresistant Pseudomonas aeruginosa (MDRP) is a serious global concern. 11 14) Therefore, more attention should be paid to the use of frequently prescribed antimicrobials (i.e., glycopeptides, oxazolidinone, carbapenems, and fourth-generation cephalosporins), and a device or system for preventing this increase in MDROs is required. Until date, in Japan, there was no generalized system that systematically supported and regulated the use of antimicrobial agents, and prescriptions were dispensed at the discretion of each physician. 15) Therefore, these physicians tended to prescribe broad spectrum antimicrobials frequently and for long durations.
A multidisciplinary team comprising physicians, nurses, pharmacists, and clinical laboratory technologists working together to take care of patients has recently become a mainstream clinical practice in Japan; this team also works with the infection control team (ICT). The importance of infection control and prevention has increased and become an indispensable factor. 16) The diagnosis procedure combination (DPC) system has been implemented for limiting healthcare costs. 17) Infection control and patient safety contribute to reduction in antimicrobial consumption and containment of healthcare costs. Patient safety practices such as continuous work improve-ment and causal analysis can strengthen the infection control and prevention program. 18) Suppression of the development of resistant microorganisms is also anticipated, and hence, the program for appropriate use of broad spectrum antimicrobials has been implemented in many hospitals. Introduction of a preauthorization and notiˆcation system, knowledge of appropriate use of antimicrobials, and pharmacokinetic analyses based on monitoring of therapeutic drugs recommended by the Japan Council for Quality Health Care (JCQHC) are also being practiced in many hospitals.
Several university hospitals introduced a preauthorization and notiˆcation system and reported an eŠect on appropriate use of antimicrobials. 19 22) We build antimicrobial usage monitoring system without introducing a pre-authorization and notiˆcation system of speciˆc antimicrobials in the Osaka University Hospital and grasp administered patients and the duration of administration. The objective of this study is to investigate an eŠect on the antimicrobial appropriate use of the antimicrobial stewardship such as consultation and education to the primary physician by the infectious disease physician and the surveillance that used antimicrobial usage monitoring system. We also investigated the administration period of speciˆc antimicrobial agents in the individual inpatient.
METHODS

Hospital Setting
Osaka University Hospital (24 wards, 30 diagnosis and treatment departments) is an advanced treatment hospital with 1076 beds. We are using an electronic record and an ordering system in our hospital. In 2007, the mean number of inpatients was 918, and the average length of hospital stay was 19.9 days. In this hospital, after physicians applied for the adoption of medical supplies, comparison of the drugs with the same indications and consideration of safety are performed by a pharmacy and therapeutic committee, and the adoption or rejection of the medical supplies is decided.
No other restrictive control measures on antimicrobial use have been implemented. Physicians can prescribe any antimicrobial in the formulary without restriction. In September 2004, the ICT has played an important role in promotion of appropriate use of broad spectrum antimicrobials and anti-MRSA agents at Osaka University Hospital (Osaka, Japan). Measurement of Antimicrobial Expenditure We obtained the amount of all antimicrobial injections iǹ`t iter'' from the medical information database of the electronic health record system. These amounts were based on prescribed doses. We retrospectively reviewed data from January 2001 to December 2007. Injectable antimicrobial consumption was measured in grams and the number of vials/ampoules. We appointed carbapenems (imipenem/cilastatin, panipenem/betamipron, meropenem, biapenem and doripenem), fourth-generation cephalosporins (cefozopran, cefepime and cefpirome) and anti-MRSA agents (arbekacin, teicoplanin, linezolid and vancomycin) as speciˆc antimicrobials in our hospital. The amount of an antimicrobial agent was expressed as deˆned daily dose (DDD) and antimicrobial use density (AUD). DDD is deˆned by the World Health Organization as the assumed mean maintenance adult daily dose of an antimicrobial agent for one day of treatment (anatomical therapeutic chemical classiˆcation/DDD index 2010). AUD was calculated to normalize the amount of antimicrobial consumption in an individual hospital. AUD was expressed as DDD per 1000 patient-days for individual antimicrobial agents (Expression 1 : AUD＝antimicrobial consumption /DDD×1000/patient-days). We calculated patient-days by subtracting the day of admission from the day of discharge. So day cases score zero patient-days. Moreover, we calculated the administration period of speciˆc antimicrobial agents in individual inpatients and investigated its change over seven years.
Monitoring Usage of Speciˆc Antimicrobials We obtained prescription data of speciˆc antimicrobials from pharmaceutical support system of a pharmacy. These data contained both administered and unadministered prescriptions. We gave these data to the ICT. Infectious disease physicians required a fair amount of time before consulting the primary physician to know the exact duration of antimicrobial administration in an individual inpatient. Therefore, in April 2007, we created an antimicrobial usage moni- toring system using MicrosoftAccess 2000 (Microsoft Corporation. 1999) for determining the time of consultation with the primary physician. Using this system, we procured a list of inpatients prescribed speciˆc antimicrobials in the preceding week and those continuously using speciˆc antimicrobials for 14 days. We provided these lists to the ICT on a weekly basis.
Isolation of MRSA We investigated the number of MRSA patients and the incidence of hospitalassociated MRSA (HA-MRSA) infection from 2003 to 2007. In order to take measures against nosocomial infection more eŠectively, we have classiˆed MRSA cases as either associated in or imported to the hospital. Genetic analysis is necessary to distinguish MRSA precisely, but this analysis is not convenient means for screening, costs money and is an inspection for an ascertainment. In our hospital, imported MRSA cases were deˆned by the following criteria:
(1) patients with MRSA isolated from any site within 48 hours after admission, (2) patients with a history of MRSA culture positive in other hospital, outpatient care and previous hospitalization. 10) The incidence of HA-MRSA infection was calculated as the percentage of HA-MRSA patients in the hospitalization number of patients. Table 1 shows the characteristics of the study population. In the seven years from 2001 to 2007, the number of inpatient admissions and operations increased 1.53-and 1.39-fold. The number of inpatients 12 years of age constituted approximately 10％ of the entire population. The mean length of hospital stay decreased by 11.5 days, and our hospital maintained the annual hospital bed occupancy rate of around 86
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Injectable Antimicrobial Consumption Annual change in the quantity of antimicrobial injections is shown in Fig. 1 . The total antimicrobial consumption decreased until 2005, but increased thereafter. The total antimicrobial consumption was 103.6 kg in 2007. Among these, cephalosporins constituted 40 Table 2) . We saved about ¥100 million a year. Table 3 shows AUD of the main antimicrobial classes. AUD of speciˆc antimicrobials decreased since 2005. In contrast, AUD of penicillins andˆrst-generation cephalosporins increased.
Changes in the Administration Period of Antimicrobial Agents
The ratio of the number of inpatients administered a speciˆc antimicrobial to the number of inpatients is shown in Table 4 . We classied the administration period into two groups: A ( 7 days) or B (＞7 days). The ratio of each group to the number of inpatients administered each speciˆc antimicrobial is also shown in Table 4 .
In the seven years from 2001 to 2007, the number of inpatients receiving carbapenems, fourth-generation cephalosporins, and anti-MRSA agents decreased from 1214 to 871, 780 to 340, and 569 to 483, respectively. The ratio of inpatients administered a speciˆc antimicrobial within seven days to the number of inpatients administered each speciˆc antimicrobial was 56.6％→63.5％, 66.9％→65.6％, and 48.  Numbers in parentheses indicate the ratio of the number of patients administered a speciˆc antimicrobials to the number of inpatients. 
DISCUSSION
The number of infectious disease physicians in Japan is fewer than that in the USA. Therefore, the ICT has also played a role of the antimicrobial stewardship team in Japan. In Osaka University Hospital, the ICT consisting of infectious disease physicians, pharmacists, nurses, clinical laboratory technologists, and medical clerical employees formed the antimicrobial stewardship team. We organized education programs with regard to infection control for medical staŠ. We also started keeping electronic medical records and computer entries of physician orders, provided patient-speciˆc culture and susceptibility data to optimize individual antimicrobial management, and performed weekly surveillance of speciˆc antimicrobial usage. Our hospital has not introduced the pre-authorization and notiˆcation system of carbapenems, fourth-generation cephalosporins, and anti-MRSA agents, even though JCQHC recommended this.
Although the number of inpatients and operations increased 1.53-and 1.39-fold from 2001 to 2007, AUD of speciˆc antimicrobials decreased by 26.3％
(from 39.6 to 29.2). Since 2005, consumption of speciˆc antimicrobials decreased gradually, and that of narrow spectrum antimicrobials such as penicillins andˆrst-generation cephalosporins increased. These results show a possibility that antimicrobials used after empiric therapy has shifted from broad spectrum antimicrobials to narrow spectrum antimicrobials. Furthermore, it is highly possible that reduction in AUD was aŠected by the activities of the ICT in the antimicrobial stewardship program and consultation as well as education of primary physicians by infectious disease physicians. The decreasing tendency of AUD continues to exist. Although we cannot say for sure that the economical incentive of DPC has no in‰uence on the current result, expenditures related to speciˆc antimicrobial injections clearly decreased. As in previous reports, 23 25) the expenditure of total antimicrobial agents also decreased markedly, with annual savings of about ¥100 million. While DPC and accreditation by JCQHC advance, prevention of hospital-associated infection and appropriate use of antimicrobial agents are indispensable for hospital management.
As a result of the survey on the administration period of speciˆc antimicrobials, the ratio of the number of inpatients administered a speciˆc antimicrobial to the number of inpatients decreased for each class of speciˆc antimicrobials. In comparison with 2001, the ratio of the number of inpatients administered a speciˆc antimicrobial within seven days to the number of inpatients administered each speciˆc antimicrobial increased in 2007, except for fourthgeneration cephalosporins. We think that this result is an accomplishment of the change from broad spectrum antimicrobial use to narrow spectrum antimicrobial use, which is eŠective for an individual causative microorganism (``de-escalation therapy'') on the basis of culture results. De-escalation therapy is an element of the antimicrobial stewardship program. 26, 27) The number of MRSA patients was almost constant throughˆve years from 2003 to 2007. But if we consider the fact that the number of inpatients admission increased greatly, we can think that the number of MRSA patients decreased. Moreover, it became clear that imported MRSA patients occupy about 40 ％ of MRSA patients. By distinguishing between HA-MRSA case and imported MRSA case, we focus on HA-MRSA and can implement the identiˆcation of the infection route and the enhancement of the infection control. Our classiˆcation criteria have the problem that all the patient specimens that were not obtained within 48 hours after hospitalization become hospital-associated infection. We think that the simple classiˆcation criteria are better, because our distinction is screening to get to know the tendency of MRSA infection. With this classiˆcation result, we can approach infection control of HA-MRSA eŠec-tively and e‹ciently.
We built antimicrobial usage monitoring system without introducing a pre-authorization and notiˆca-tion system of speciˆc antimicrobials in the Osaka University Hospital. We grasped administered patients and the administration period of speciˆc antimicrobials in the individual patient by monitoring a status of antimicrobial use and prevented emergence of resistant microorganisms. We think that both eŠect of consultation/education to the primary physician and consciousness (Hawthorne eŠect) that use of the antimicrobial is always monitored by speciˆc antimicrobial usage monitoring system led the decrease of the speciˆc antimicrobial consumption and the reduction of drug costs. The decrease of the administration period of the speciˆc antimicrobial and the decrease of the incidence of the HA-MRSA were found. Therefore, we think that the antimicrobial therapy of high dose/short duration based on Pharmacokinetics-Pharmacodynamics theory is performed progressively, and the appropriate use of antimicrobial is achieved.
